NDC 0061-1435 - Numelvi
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0061-1435
- Package NDCs from labels
- 0061-1435-01, 0061-1435-02
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2026-08-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Numelvi™ (atinvicitinib tablets) | Merck Sharp & Dohme Corp. | 2026-08-04 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0061-1435-01 | Numelvi | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 1 | |
| 0061-1435-01 | Numelvi | 1 in 1 CARTON | TABLET | 1 | 1 | |
| 0061-1435-02 | Numelvi | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 1 | |
| 0061-1435-02 | Numelvi | 1 in 1 CARTON | TABLET | 1 | 1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.